Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
Spremljeno u:
Chen, L.S., ET AL., Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction, Vol. 109, no. 1 (2014), p. 128-139.
Ref.
196549
Lokacija:
SIIS R.696 Archivo
Palabras clave:
Drogodependencias, Efectos, Fármacos, Genética, Nicotina de sustitución, Programas de mantenimiento, Reducción de daños, Resultados, Tabaquismo, Tratamiento médico
Drogodependencias, Efectos, Fármacos, Genética, Nicotina de sustitución, Programas de mantenimiento, Reducción de daños, Resultados, Tabaquismo, Tratamiento médico
Slični predmeti: Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
- Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)
- The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy
- PHARMACOTHERAPIES TO ENHANCE SMOKING CESSATION DURING PREGNANCY
- ASSOCIATION OF CYP2D6 ULTRARAPID METABOLIZER GENOTYPE WITH DEFICIENT PATIENT SATISFACTION REGARDING METHADONE MAINTENANCE TRATMENT
- AN ALGORITHM FOR TAILORING PHARMACOTHERAPY FOR SMOKING CESSATION: RESULTS FROM A DELPHI PANEL OF INTERNATIONAL EXPERTS
- USE OF NICOTINE REPLACEMENT HTERAPY TO REDUCE OR DELAY SMOKING BUT NOT TO QUIT: PREVALENCE AND ASSOCIATION WITH SUBSEQUENT CESSATION EFFORTS